ClinicalTrials.Veeva

Menu

Massive Nasal Bleeding in Patients With NPC Received Curative RT

T

Taichung Veterans General Hospital

Status

Completed

Conditions

Nasopharyngeal Carcinoma Patients Treated With Curative Radiotherapy

Treatments

Other: Patients with massive nasal bleeding
Other: Patients without massive nasal bleeding

Study type

Observational

Funder types

Other

Identifiers

NCT06348485
VGHTCCTC_NPCbleeding001

Details and patient eligibility

About

To investigate the incidence, predictive markers, and survival impact of massive nasal bleeding in nasopharyngeal carcinoma (NPC) patients who received curative radiotherapy (RT) with/without chemotherapy. A total of 1327 patients with previously untreated, biopsy-proven NPC, and no distant metastasis were retrospective reviewed. Investigators analyzed the occurrence rates of massive nasal bleeding between different characteristics and tried to identify important predictive factors. Investigators compared overall survival between patients with and without massive nasal bleeding by Kaplan-Meier method.

Enrollment

1,327 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • previously untreated, biopsy-proven NPC
  • no distant metastasis

Exclusion criteria

  • incomplete record of history or treatment

Trial design

1,327 participants in 1 patient group

NPC received Curative radiotherapy
Treatment:
Other: Patients without massive nasal bleeding
Other: Patients with massive nasal bleeding

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems